Trial · NCT01331681
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intravitreal Aflibercept Injection 2Q4 | 136 | |
| Overall Study | STARTED | Intravitreal Aflibercept Injection 2Q8 | 135 | |
| Overall Study | STARTED | Macular Laser Photocoagulation (Control) | 135 | |
| Overall Study | Participants Received Treatment | Intravitreal Aflibercept Injection 2Q4 | 136 | |
| Overall Study | Participants Received Treatment | Intravitreal Aflibercept Injection 2Q8 | 135 | |
| Overall Study | Participants Received Treatment | Macular Laser Photocoagulation (Control) | 133 | |
| Overall Study | Completed Week 52 | Intravitreal Aflibercept Injection 2Q4 | 125 | |
| Overall Study | Completed Week 52 | Intravitreal Aflibercept Injection 2Q8 | 121 | |
| Overall Study | Completed Week 52 | Macular Laser Photocoagulation (Control) | 115 | |
| Overall Study | Completed Week 100 | Intravitreal Aflibercept Injection 2Q4 | 115 | |
| Overall Study | Completed Week 100 | Intravitreal Aflibercept Injection 2Q8 | 110 | |
| Overall Study | Completed Week 100 | Macular Laser Photocoagulation (Control) | 105 | |
| Overall Study | Completed Week 148 | Intravitreal Aflibercept Injection 2Q4 | 101 | |
| Overall Study | Completed Week 148 | Intravitreal Aflibercept Injection 2Q8 | 101 | |
| Overall Study | Completed Week 148 | Macular Laser Photocoagulation (Control) | 100 | |
| Overall Study | COMPLETED | Intravitreal Aflibercept Injection 2Q4 | 101 | |
| Overall Study | COMPLETED | Intravitreal Aflibercept Injection 2Q8 | 101 | |
| Overall Study | COMPLETED | Macular Laser Photocoagulation (Control) | 100 | |
| Overall Study | NOT COMPLETED | Intravitreal Aflibercept Injection 2Q4 | 35 | |
| Overall Study | NOT COMPLETED | Intravitreal Aflibercept Injection 2Q8 | 34 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01331681/flow